» Articles » PMID: 21390302

Synaptic Dysbindin-1 Reductions in Schizophrenia Occur in an Isoform-specific Manner Indicating Their Subsynaptic Location

Overview
Journal PLoS One
Date 2011 Mar 11
PMID 21390302
Citations 44
Authors
Affiliations
Soon will be listed here.
Abstract

Background: An increasing number of studies report associations between variation in DTNBP1, a top candidate gene in schizophrenia, and both the clinical symptoms of the disorder and its cognitive deficits. DTNBP1 encodes dysbindin-1, reduced levels of which have been found in synaptic fields of schizophrenia cases. This study determined whether such synaptic reductions are isoform-specific.

Methodology/principal Findings: Using Western blotting of tissue fractions, we first determined the synaptic localization of the three major dysbindin-1 isoforms (A, B, and C). All three were concentrated in synaptosomes of multiple brain areas, including auditory association cortices in the posterior half of the superior temporal gyrus (pSTG) and the hippocampal formation (HF). Tests on the subsynaptic tissue fractions revealed that each isoform is predominantly, if not exclusively, associated with synaptic vesicles (dysbindin-1B) or with postsynaptic densities (dysbindin-1A and -1C). Using Western blotting on pSTG (n = 15) and HF (n = 15) synaptosomal fractions from schizophrenia cases and their matched controls, we discovered that synaptic dysbindin-1 is reduced in an isoform-specific manner in schizophrenia without changes in levels of synaptophysin or PSD-95. In pSTG, about 92% of the schizophrenia cases displayed synaptic dysbindin-1A reductions averaging 48% (p = 0.0007) without alterations in other dysbindin-1 isoforms. In the HF, by contrast, schizophrenia cases displayed normal levels of synaptic dysbindin-1A, but 67% showed synaptic reductions in dysbindin-1B averaging 33% (p = 0.0256), while 80% showed synaptic reductions in dysbindin-1C averaging 35% (p = 0.0171).

Conclusions/significance: Given the distinctive subsynaptic localization of dysbindin-1A, -1B, and -1C across brain regions, the observed pSTG reductions in dysbindin-1A are postsynaptic and may promote dendritic spine loss with consequent disruption of auditory information processing, while the noted HF reductions in dysbindin-1B and -1C are both presynaptic and postsynaptic and could promote deficits in spatial working memory.

Citing Articles

Dysbindin-1 Mutation Alters Prefrontal Cortex Extracellular Glutamate and Dopamine In Vivo.

Szumlinski K, Datko M, Lominac K, Jentsch J Int J Mol Sci. 2024; 25(23).

PMID: 39684450 PMC: 11640900. DOI: 10.3390/ijms252312732.


Expression of Concern: Synaptic Dysbindin-1 Reductions in Schizophrenia Occur in an Isoform-Specific Manner Indicating Their Subsynaptic Location.

PLoS One. 2024; 19(3):e0301152.

PMID: 38507352 PMC: 10954157. DOI: 10.1371/journal.pone.0301152.


Dysregulated Signaling at Postsynaptic Density: A Systematic Review and Translational Appraisal for the Pathophysiology, Clinics, and Antipsychotics' Treatment of Schizophrenia.

de Bartolomeis A, Vellucci L, De Simone G, Mazza B, Barone A, Ciccarelli M Cells. 2023; 12(4).

PMID: 36831241 PMC: 9954794. DOI: 10.3390/cells12040574.


Exposure to Circadian Disruption During Adolescence Interacts With a Genetic Risk Factor to Modify Schizophrenia-relevant Behaviors in a Sex-dependent Manner.

Cloutier M, Srivastava L, Cermakian N J Biol Rhythms. 2022; 37(6):655-672.

PMID: 36168739 PMC: 9749568. DOI: 10.1177/07487304221125363.


Dysbindin-1A modulation of astrocytic dopamine and basal ganglia dependent behaviors relevant to schizophrenia.

Mastrogiacomo R, Trigilio G, Devroye C, Dautan D, Ferretti V, Losi G Mol Psychiatry. 2022; 27(10):4201-4217.

PMID: 35821415 DOI: 10.1038/s41380-022-01683-8.


References
1.
Cox M, Tucker A, Tang J, Talbot K, Richer D, Yeh L . Neurobehavioral abnormalities in the dysbindin-1 mutant, sandy, on a C57BL/6J genetic background. Genes Brain Behav. 2009; 8(4):390-7. PMC: 2774142. DOI: 10.1111/j.1601-183X.2009.00477.x. View

2.
Burdick K, Lencz T, Funke B, Finn C, Szeszko P, Kane J . Genetic variation in DTNBP1 influences general cognitive ability. Hum Mol Genet. 2006; 15(10):1563-8. DOI: 10.1093/hmg/ddi481. View

3.
Barch D . The cognitive neuroscience of schizophrenia. Annu Rev Clin Psychol. 2007; 1:321-53. DOI: 10.1146/annurev.clinpsy.1.102803.143959. View

4.
Ryder P, Faundez V . Schizophrenia: the "BLOC" may be in the endosomes. Sci Signal. 2009; 2(93):pe66. PMC: 5696790. DOI: 10.1126/scisignal.293pe66. View

5.
Brugge J, Volkov I, Oya H, Kawasaki H, Reale R, Fenoy A . Functional localization of auditory cortical fields of human: click-train stimulation. Hear Res. 2008; 238(1-2):12-24. PMC: 5605818. DOI: 10.1016/j.heares.2007.11.012. View